Autor der Publikation

Coupling of C3b to erythrocytes by disulfide bond formation: preparation of EC3b for hemolytic and complement receptor assays.

, , , , und . Journal of Immunological Methods, 65 (3): 277--283 (Dezember 1983)

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

 

Weitere Publikationen von Autoren mit dem selben Namen

Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H., , , , und . The Biochemical journal, 232 (3): 841--850 (Dezember 1985)Molecular aspects of C3 interactions and structural/functional analysis of C3 from different species., , und . Current topics in microbiology and immunology, (1990)Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21)., , , , , , und . European journal of immunology, 21 (11): 2829--2838 (November 1991)Cell surface proteins reacting with activated complement components., , , , und . Complement and inflammation, 6 (3): 142--165 (1989)Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H., , , und . The Biochemical journal, 224 (2): 389--398 (Dezember 1984)Structural and functional analysis of C3 using monoclonal antibodies., , , und . Current topics in microbiology and immunology, (1990)Use of monoclonal antibodies against factor H to investigate the role of a membrane-associated protein antigenically related to H in C3b-receptor function., , , , und . Journal of immunology (Baltimore, Md. : 1950), 132 (1): 392--398 (Januar 1984)Importance of factors H and I for the adherence of C3b-coated erythrocytes to cells., , , , , und . 165 (2): 211--224 (August 1983)Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies., , , und . The Journal of clinical investigation, 83 (6): 1794--1799 (Juni 1989)Phylogeny of the third component of complement, C3: analysis of the conservation of human CR1, CR2, H, and B binding sites, concanavalin A binding sites, and thiolester bond in the C3 from different species., , , , , , , , und . Developmental and comparative immunology, 16 (1): 63--76 (Januar 1992)